Tesetaxel
- Generic Name
- Tesetaxel
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C46H60FN3O13
- CAS Number
- 333754-36-2
- Unique Ingredient Identifier
- UG97LO5M8Y
- Background
Tesetaxel has been used in trials studying the treatment of Cancer, Melanoma, Prostate Cancer, Gastric Carcinoma, and Advanced Melanoma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Phase II Study of Tesetaxel in Metastatic Melanoma
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01064713
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath